Cargando…
Maternal vaccination with a type-III glycoconjugate protects mouse neonates against Group B Streptococcus intranasal infection
Group B Streptococcus (GBS) is generally an asymptomatic colonizer of human mucosa but it occasionally infects pregnant women and neonates through vertical transmission, causing disease during the first weeks of life with frequent and severe complications. Preclinical studies have shown that materna...
Autores principales: | Chiarot, Emiliano, Naimo, Eleonora, Corrado, Alessia, Giannetti, Patrizia, Ros, Immaculada Margarit Y., Bensi, Giuliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560876/ https://www.ncbi.nlm.nih.gov/pubmed/34725414 http://dx.doi.org/10.1038/s41598-021-00941-z |
Ejemplares similares
-
Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models
por: Chiarot, Emiliano, et al.
Publicado: (2018) -
Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen
por: Fantappiè, Laura, et al.
Publicado: (2014) -
Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A Streptococcus Virulence
por: Chiarot, Emiliano, et al.
Publicado: (2013) -
Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes
por: McKenna, Sophie, et al.
Publicado: (2020) -
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
por: Campisi, Edmondo, et al.
Publicado: (2021)